TransMedics Group, Inc.TMDXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-50.8%
5Y CAGR+31.4%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-50.8%/yr
vs +7.5%/yr prior
5Y CAGR
+31.4%/yr
Recent deceleration
Acceleration
-58.3pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
20259.82%
202441.04%
202371.04%
202282.58%
202158.27%
20202.51%
201991.60%
201861.91%
2017-6.27%
20160.00%